Accéder au contenu
Merck

Rat Model of Cockayne Syndrome Neurological Disease.

Cell reports (2019-10-24)
Yingying Xu, Zhenzhen Wu, Lingyun Liu, Jiena Liu, Yuming Wang
RÉSUMÉ

Cockayne syndrome (CS) is a rare genetic neurodevelopmental disorder, characterized by a deficiency in transcription-coupled subpathway of nucleotide excision DNA repair (TC-NER). Mutation of the Cockayne syndrome B (CSB) gene affects basal transcription, which is considered a major cause of CS neurologic dysfunction. Here, we generate a rat model by mimicking a nonsense mutation in the CSB gene. In contrast to that of the Csb-/- mouse models, the brains of the CSB-deficient rats are more profoundly affected. The cerebellar cortex shows significant atrophy and dysmyelination. Aberrant foliation of the cerebellum and deformed hippocampus are visible. The white matter displays high glial fibrillary acidic protein (GFAP) staining indicative of reactive astrogliosis. RNA sequencing (RNA-seq) analysis reveals that CSB deficiency affects the expression of hundreds of genes, many of which are neuronal genes, suggesting that transcription dysregulation could contribute to the neurologic disease seen in the CSB rat models.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Potassium bromate, ACS reagent, ≥99.8%
Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
Formaldéhyde solution, ACS reagent, 37 wt. % in H2O, contains 10-15% Methanol as stabilizer (to prevent polymerization)
Sigma-Aldrich
Triton X-100 reduced